Skip to main content
. 2019 Feb 6;9:1480. doi: 10.1038/s41598-018-35942-y

Table 1.

Diagnostic performance of different test combinatons.

Valid %* Sensitivity
(95% CI)
Specificity
(95% CI)
PPV
(95% CI)
NPV
(95% CI)
AUC* Kappa* P value*
Xpert/RIF on SF 97.6 0.28 (0.19–0.40) 1.00 (0.80–1.00) 1.00 (0.83–1.00) 0.23 (0.15–0.35) 0.650 0.11 0.008
Xpert/RIF on SFDFP 85.5 0.36 (0.25–0.48) 1.00 (0.78–1.00) 1.00 (0.85–1.00) 0.27 (0.17–0.40) 0.679 0.16 0.359
Smear on SF 100 0.07 (0.03–0.16) 1.00 (0.77–1.00) 1.00 (0.57–1.00) 0.27 (0.17–0.26) 0.536 0.02 0.000
Culture on SF 98.8 0.20 (0.12–0.31) 1.00 (0.76–1.00) 1.00 (0.78–1.00) 0.18 (0.10–0.28) 0.554 0.07 0.000
Smear on SFDFP 89.2 0.15 (0.08–0.25) 1.00 (0.76–1.00) 1.00 (0.70–1.00) 0.18 (0.11–0.30) 0.578 0.05 0.000
Culture on SFDFP 89.2 0.16 (0.09–0.27) 1.00 (0.76–1.00) 1.00 (0.72–1.00) 0.19 (0.11–0.30) 0.585 0.06 0.001
Pathology on SFDFP 86.7 0.19 (0.11–0.30) 1.00 (0.77–1.00) 1.00 (0.74–1.00) 0.21 (0.13–0.33) 0.657 0.08 0.001
S + C on SF 100 0.24 (0.16–0.35) 1.00 (0.77–1.00) 1.00 (0.82–1.00) 0.20 (0.12–0.31) 0.621 0.09 0.002
S + C on SFDFP 89.2 0.16 (0.09–0.27) 1.00 (0.76–1.00) 1.00 (0.72–1.00) 0.19 (0.11–0.30) 0.585 0.06 0.001
S + C + P on SFDFP 90.4 0.26 (0.17–0.38) 1.00 (0.77–1.00) 1.00 (0.81–1.00) 0.22 (0.13–0.34) 0.671 0.11 0.013
S + C + X on SF 100 0.41 (0.31–0.53) 1.00 (0.77–1.00) 1.00 (0.88–1.00) 0.24 (0.15–0.37) 0.707 0.18
S + C + P + X on SFDFP 91.6 0.48 (0.36–0.60) 1.00 (0.77–1.00) 1.00 (0.89–1.00) 0.28 (0.17–0.43) 0.764 0.24 1.000
All on SFDFP & SF 100 0.60 (0.48–0.71) 1.00 (0.77–1.00) 1.00 (0.92–1.00) 0.32 (0.20–0.47) 0.800 0.32 0.004
Elispot on PBMCs* 100 0.63 (0.51–0.73) 0.69 (0.42–0.87) 0.92 (0.80–0.97) 0.26 (0.14–0.42) 0.660 0.19 0.007

Notes: Abbreviated Words: “S” means smear; “C” means culture; “P” means histopathologic examination; “X” means Xpert assay; “SF” means serious fluid; “SFDFP” means serous fluid drainage flocky precipitate.

*“Valid” means the proportion of cases with available sample and results for all analyzed cases; “AUC” means the area under the receiver operating characteristic (ROC) curve. “Kappa” value was used to assess the agreement between the test (or test combination) and the composite reference standard (categorized as TB serositis or non-TB serositis). “p value” referred to the “S + C + X on SF” row, which stands for the routine decision-making tests to “confirm TB serositis”. The “p value” here was used to assess the statistical significance to our routine definitive methods. “Elispot on PBMC” means T-Spot test on blood samples.